A study led by researchers from the University of Granada, carried out in collaboration with the University of Castilla-La Mancha and the Radboud University Medical Center (The Netherlands), has shown ...

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth ...

To evaluate the cost utility of a 9-month supervised exercise program for patients with metastatic breast cancer (mBC), compared with control (usual care, supplemented with general activity advice and ...

Introduction Physical exercise has been used to assist smoking cessation, but supervised programmes are bounded by limited ...

A supervised exercise already shown to alleviate fatigue and other side effects in patients with metastatic breast cancer has now been found to also be cost analysis. Anne May, PhD, of Utrecht ...

This supports the call for exercise, and specifically supervised exercise with a resistance exercise component, to be integrated as a standard component of cancer care for patients with metastatic ...

Aerobic exercise (AE) group increased their aerobic activity intensity, and resistance exercise (RE) group improved their resistance activity scores, compared to control group. As the global ...

Mothers who followed a supervised exercise program throughout pregnancy had babies with lower BMI and reduced odds of overweight at 12 months, offering new clues about how prenatal lifestyle habits ...

So what about exercise? Our new research confirms physical activity can be just as effective for some people as therapy or medication. This is especially true when it's social and guided by a ...

Physical activity, especially through face-to-face programs, reduces depression and anxiety in these patients. A study led by researchers from the University of Granada, carried out in collaboration ...

Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: The Phase ...